21. CTNI-18. PHASE I AND PRELIMINARY PHASE 0 RESULTS OF ABTC 1801: A MULTI-ARM CLINICAL TRIAL OF THE PARP INHIBITOR PAMIPARIB (BGB290) WITH VERY LOW DOSE METRONOMIC TEMOZOLOMIDE IN RECURRENT IDH MUTANT GLIOMAS. (12th November 2021) Authors: Schiff, David; Bindra, Ranjit; Li, Jing; Ye, Xiaobu; Ellingson, Benjamin; Walbert, Tobias; Campian, Jian; Nabors, L Burt; Lieberman, Frank; Ozer, Byran; Desai, Arati; Omuro, Antonio; Wen, Patrick; Desideri, Serena; Fisher, Joy; Grossman, Stuart Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. CTNI-29. CODEL: PHASE III TRIAL OF RT ALONE, RT PLUS TMZ, OR TMZ ALONE FOR NEWLY-DIAGNOSED, 1p/19q CODELETED ANAPLASTIC OLIGODENDROGLIOMA. ANALYSIS FROM THE INITIAL STUDY DESIGN. (NCCTG N0577, ALLIANCE). (9th November 2020) Authors: Jaeckle, Kurt; Ballman, Karla; van den Bent, Martin; Giannini, Caterina; Galanis, Evanthia; Brown, Paul; Jenkins, Robert; Cairncross, Gregory; Wick, Wolfgang; Weller, Michael; Aldape, Kenneth; Dixon, Jesse; Anderson, S Keith; Cerhan, Jane; Wefel, Jeffrey S; Klein, Martin; Grossman, Stuart; Schiff... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. CTNI-38. PAMIPARIB IN COMBINATION WITH RADIATION THERAPY (RT) AND/OR TEMOZOLOMIDE (TMZ) IN PATIENTS WITH NEWLY DIAGNOSED (ND) OR RECURRENT/REFRACTORY (R/R) GLIOBLASTOMA (GBM); PHASE 1B/2 STUDY UPDATE. (9th November 2020) Authors: Piotrowski, Anna; Puduvalli, Vinay; Wen, Patrick; Colman, Howard; Campian, Jian; Pearlman, Michael; Butowski, Nicholas; Cloughesy, Timothy; Battiste, James; Glass, Jon; Schiff, David; van den Bent, Martin; Walbert, Tobias; Ahluwalia, Manmeet; Badruddoja, Michael; Kalra, Amandeep; Pelham, Robert; ... Journal: Neuro-oncology Issue: Volume 22(2020)Supplement 2 Page Start: ii51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. CTNI-40. EVALUATING FEASIBILITY AND EFFICIENCY OF PHASE II ADAPTIVE PLATFORM TRIAL DESIGNS BASED ON THE INDIVIDUALIZED SCREENING TRIAL OF INNOVATIVE GLIOBLASTOMA THERAPY (INSIGhT) EXPERIENCE. (12th November 2021) Authors: Rahman, Rifaquat; Trippa, Lorenzo; Lee, Eudocia Quant; Arrillaga-Romany, Isabel; Touat, Mehdi; Fell, Geffrey; McCluskey, Christine; Bruno, Jennifer; Gaffey, Sarah; Drappatz, Jan; Lassman, Andrew; Galanis, Evanthia; Ahluwalia, Manmeet; Colman, Howard; Nabors, L Burt; Hepel, Jaroslaw; Elinzano, Hei... Journal: Neuro-oncology Issue: Volume 23: Supplement 6(2021) Page Start: vi68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells. Issue 10 (1st October 2016) Authors: Ledur, Pítia F.; Liu, Chong; He, Hua; Harris, Alexandra R.; Minussi, Darlan C.; Zhou, Hai-Yan; Shaffrey, Mark E.; Asthagiri, Ashok; Lopes, Maria Beatriz S.; Schiff, David; Lu, Yi-Cheng; Mandell, James W.; Lenz, Guido; Zong, Hui Journal: Neuro-oncology Issue: Volume 18:Issue 10(2016:Oct.) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Dasatinib in recurrent glioblastoma: failure as a teacher. Issue 7 (10th May 2015) Authors: Schiff, David; Sarkaria, Jann Journal: Neuro-oncology Issue: Volume 17:Issue 7(2015:Jul.) Page Start: 910 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Defining optimal initial therapy for primary CNS lymphoma. Issue 5 (May 2016) Authors: Schiff, David; Hong, Fangxin; Alexander, Brian Journal: Lancet Issue: Volume 3:Issue 5(2016) Page Start: e206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. EANO - EURACAN - SNO Guidelines on circumscribed astrocytic gliomas, glioneuronal, and neuronal tumors. Issue 12 (1st August 2022) Authors: Rudà, Roberta; Capper, David; Waldman, Adam D; Pallud, Johan; Minniti, Giuseppe; Kaley, Thomas J; Bouffet, Eric; Tabatabai, Ghazaleh; Aronica, Eleonora; Jakola, Asgeir S; Pfister, Stefan M; Schiff, David; Lassman, Andrew B; Solomon, David A; Soffietti, Riccardo; Weller, Michael; Preusser, Matthia... Journal: Neuro-oncology Issue: Volume 24:Issue 12(2022) Page Start: 2015 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. EANO, SNO and Euracan consensus review on the current management and future development of intracranial germ cell tumors in adolescents and young adults. Issue 4 (1st November 2021) Authors: Frappaz, Didier; Dhall, Girish; Murray, Matthew J; Goldman, Stuart; Faure Conter, Cecile; Allen, Jeffrey; Kortmann, Rolf Dieter; Haas-Kogen, Daphne; Morana, Giovanni; Finlay, Jonathan; Nicholson, James C; Bartels, Ute; Souweidane, Mark; Schönberger, Stefan; Vasiljevic, Alexandre; Robertson, Patri... Journal: Neuro-oncology Issue: Volume 24:Issue 4(2022) Page Start: 516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Evolution of brain lesions in a patient with TREX1 cerebroretinal vasculopathy. (3rd November 2015) Authors: Dhamija, Radhika; Schiff, David; Lopes, M. Beatriz S.; Jen, Joanna C.; Lin, Doris D.; Worrall, Bradford B. Journal: Neurology Issue: Volume 85:Number 18(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗